This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Patent Foramen Ovale (PFO) is a common congenital atrial septal defect present in 20%–35% of the general population. Although generally considered a benign anatomic variant, a PFO may facilitate passage of a thrombus from the venous to arterial circulation, thereby resulting in cryptogenic stroke or systemic embolization.
Patent foramen ovale (PFO) is the most common congenital intracardiac defect that can cause right-to-left shunting and contribute to the paradoxical embolization of venous emboli, and even lead to stroke. Studies have shown that HES can affect the nervous system and may be associated with cerebral infarction.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionVein of Galen Malformations (VOGM) are congenital brain arteriovenous malformations which often present during the neonatal or infantile periods. This difference persisted after controlling for age at initial presentation.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Given the potential vertebrobasilar inadvertent embolization, the procedure was performed under continuous neurophysiological monitoring and post‐periprocedural therapeutic anticoagulation.
Stroke, Volume 56, Issue Suppl_1 , Page A132-A132, February 1, 2025. Introduction:Vein of Galen malformations (VOGM) are challenging congenital arteriovenous malformations (AVMs) to treat. During management, for unknown reasons, VOGM may develop fine angiogenic networks of feeding vessels within subarachnoid spaces.
Stroke, Volume 55, Issue Suppl_1 , Page AWP221-AWP221, February 1, 2024. Introduction:Vein of Galen Malformations (VOGM) are congenital arteriovenous malformations which carry a mortality of 76.7% Outcomes have improved over time with advances in endovascular embolization. in untreated patients.
Congenital Heart Defects Some individuals are born with heart defects that cause parts of the heart to work harder, leading to enlargement over time. Blood Clots: An enlarged heart is more prone to developing blood clots, which can lead to stroke or pulmonary embolism.
stroke), peripheral arterial disease, congenital heart anomalies, deep vein thrombosis, and pulmonary embolism. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease (e.g.,
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content